Harvard Bioscience Inc (HBIO)

2.14 +0.11 (+5.42%) USD  |  NASDAQ  |  Jan 03, 16:00
2.47 +0.33 (+15.42%) After-Hours: 04:19
More

Harvard Bioscience Research and Development Expense (Annual): 11.76M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for HBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Bruker Corp 294.80M
Azenta Inc 33.52M
Bionano Genomics Inc 54.03M
Akoya Biosciences Inc 21.89M
Singular Genomics Systems Inc 47.76M